Products
Chloramphenicol 250mg Capsules Aminophylline anhydrous – Runquankang
Chloramphenicol 250mg Capsules Aminophylline anhydrous – Runquankang Detail:
Synonyms：
● 3,7-Dihydro-1,3-dimethylpurine-2,6-dione, complex with 1,2-ethanediamine (2:1)
● Theophylline hemi(ethylenediamine) complex
● Aminophylline anhydrous
● Theophylline, compound with ethylenediamine (2 to 1) dihydrate
● Aminophylline hydrate
● Aminophyllin Hydrate
● Theophylline–Ethylenediamine (2:1)
● 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione – ethane-1,2-diamine (2:1)
● 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione – ethane-1,2-diamine (1:1)
SPECIFICATION:
| Items | Specification |
| Appearance | White or slightly yellowish powder or granule |
| Identification: IR | Conforms to reference spectrum |
| Melting point (precipitate) | 248 – 252 C |
| Related substances | ≤0.10% |
| Total impurities | ≤0.1% |
| Sulphated ash | ≤0.1% |
| Theopylline Assay | 84.0-87.4% |
| Ethylenediamine Assay | 13.5 – 15.0% |
Packing: 25kg/drum 25kg/ctn or per customers’requirement
Factory Supply Ability: 120 kgs/ year
Lead time: within 3-5 days
Payment Terms： TT LC DP
Sample： sample is available
Transport：
*sample by express, such as Fedex, DHL, EMS, TNT
*small quantity by air
*big quantity by sea
Mainly export to : India, USA, Russia, Turkey, Africa, Pakistan, Kazakhstan, Ghana, etc.
Pharmaceutical Raw Material API Manufacturer and Supplier in China
Factory Name: Jiangxi Runquankang Biological Technology Co., Ltd.
Factory Address: Industrial Park of Guantian town, Chongyi county, Ganzhou city, Jiangxi Province, China.
Registered Capital: RMB50,000,000.00
Factory Area: 15,700 square meters
Employee: 99
Main Pharmacutical raw material, APIs:
Chloramphenicol， Dl-chloramphenicol, Sodium Saccharin，Heparin Sodium, Bilirubin, Caffeine anhydrous, Theophylline anhydrous , Aminophylline anhydrous.
Aminophylline is a compound salt of theophylline and ethylenediamine. Its pharmacological action mainly comes from theophylline,and ethylenediamine enhances its water solubility. Insoluble in methanol, ethanol, ether. This product has direct relaxation effect on respiratory tract smooth muscle, and its mechanism of action is relatively complex.Aminophylline is a compound of the bronchodilator theophylline with ethylenediamine in 2:1 ratio.Aminophylline is less potent and shorter-acting than theophylline. Its most common use is in the treatment of airway obstruction from asthma or COPD.
Aminophylline can be used as dicuretic and the medicine helping to relax the smooth muscle .The aminophylline can relax the bronchus and the smooth muscle of the blood vessel,inhibit the kidney tubules to reabsorb the sodium and the water and enhance the extraction of heart oedema and so on .It is usually used as mono-medicine.It is mainly used in medicine field.
Application:
A drug combination that contains theophylline and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It’s most common use is in bronchial asthma, but it has been investigated for several other applications
Product detail pictures:
Related Product Guide:
We rely upon strategic thinking, constant modernisation in all segments, technological advances and of course upon our employees that directly participate in our success for Chloramphenicol 250mg Capsules Aminophylline anhydrous – Runquankang , The product will supply to all over the world, such as: Jamaica, Madagascar, Cyprus, We welcome you to visit our company and factory. It is also convenient to visit our website. Our sales team will offer you the best service. If you need more information, please feel free to contact us by E-mail or telephone. We are sincerely hope to establish a good long-term business relationship with you through this opportunity, based on equal, mutual benefit from now till the future.
By Alice from Porto - 2017.06.19 13:51
The factory has advanced equipment, experienced staffs and good management level, so product quality had assurance, this cooperation is very relaxed and happy!
By Christian from azerbaijan - 2018.06.26 19:27
